ALPRAZOLAM
- Product NDC
- 63629-1541
- 11-digit product format
- 636291541
- Labeler code
- 63629
- Product ID
- 63629-1541_76f07536-e338-4984-ba2a-148ce9c5a92d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ALPRAZOLAM
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA077996
- Marketing category
- ANDA
- Marketing start
- 2007-03-28
- Marketing end
- 0000-00-00
- Substance
- ALPRAZOLAM
- Active strength
- 1 mg/1
- Pharmacologic classes
- Benzodiazepine [EPC],Benzodiazepines [CS]
- DEA schedule
- CIV
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 63629-1541 | D | Discontinued by firm | 2026-10-05 | ||
| excluded package | package | 63629-1541 | 63629-1541-0 | D | Discontinued by firm | 2026-10-05 | |
| excluded package | package | 63629-1541 | 63629-1541-1 | D | Discontinued by firm | 2026-10-05 | |
| excluded package | package | 63629-1541 | 63629-1541-2 | D | Discontinued by firm | 2026-10-05 | |
| excluded package | package | 63629-1541 | 63629-1541-3 | D | Discontinued by firm | 2026-10-05 | |
| excluded package | package | 63629-1541 | 63629-1541-4 | D | Discontinued by firm | 2026-10-05 | |
| excluded package | package | 63629-1541 | 63629-1541-5 | D | Discontinued by firm | 2026-10-05 | |
| excluded package | package | 63629-1541 | 63629-1541-6 | D | Discontinued by firm | 2026-10-05 | |
| excluded package | package | 63629-1541 | 63629-1541-7 | D | Discontinued by firm | 2026-10-05 | |
| excluded package | package | 63629-1541 | 63629-1541-8 | D | Discontinued by firm | 2026-10-05 | |
| excluded package | package | 63629-1541 | 63629-1541-9 | D | Discontinued by firm | 2026-10-05 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded product | product | d630ba8d3edf… | 732f749b63fb… | |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 63629-1541-3 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 63629-1541-6 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 63629-1541-7 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 63629-1541-9 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 63629-1541-1 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 63629-1541-8 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 63629-1541-4 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 63629-1541-5 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 63629-1541-2 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 63629-1541-0 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded product | product | f5e01cc5f278… | a2eaf40c39c3… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 63629-1541-3 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 63629-1541-6 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 63629-1541-7 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 63629-1541-9 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 63629-1541-1 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 63629-1541-8 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 63629-1541-4 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 63629-1541-5 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 63629-1541-2 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 63629-1541-0 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 63629-1541-3 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 63629-1541-6 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 63629-1541-7 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 63629-1541-9 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 63629-1541-1 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 63629-1541-8 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 63629-1541-4 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 63629-1541-5 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 63629-1541-2 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 63629-1541-0 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 63629-1541-3 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 63629-1541-6 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 63629-1541-7 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 63629-1541-9 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 63629-1541-1 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 63629-1541-8 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 63629-1541-4 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 63629-1541-5 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 63629-1541-2 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 63629-1541-0 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 63629-1541-3 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 63629-1541-6 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 63629-1541-7 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 63629-1541-9 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 63629-1541-1 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 63629-1541-8 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 63629-1541-4 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 63629-1541-5 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 63629-1541-2 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 63629-1541-0 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 63629-1541-3 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 63629-1541-6 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 63629-1541-7 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 63629-1541-9 | cdf11ea48f46… | ba0047e9e063… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A077996-001 | ALPRAZOLAM | ALPRAZOLAM | 0.5MG | TABLET, EXTENDED RELEASE / ORAL | 2007-01-31 | ||
| A077996-002 | ALPRAZOLAM | ALPRAZOLAM | 1MG | TABLET, EXTENDED RELEASE / ORAL | 2007-01-31 | ||
| A077996-003 | ALPRAZOLAM | ALPRAZOLAM | 2MG | TABLET, EXTENDED RELEASE / ORAL | 2007-01-31 | ||
| A077996-004 | ALPRAZOLAM | ALPRAZOLAM | 3MG | TABLET, EXTENDED RELEASE / ORAL | 2007-01-31 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A077996-001 | ALPRAZOLAM | 0.5MG | TABLET, EXTENDED RELEASE / ORAL | 2007-01-31 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A077996-002 | ALPRAZOLAM | 1MG | TABLET, EXTENDED RELEASE / ORAL | 2007-01-31 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A077996-003 | ALPRAZOLAM | 2MG | TABLET, EXTENDED RELEASE / ORAL | 2007-01-31 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A077996-004 | ALPRAZOLAM | 3MG | TABLET, EXTENDED RELEASE / ORAL | 2007-01-31 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A077996-001 | ALPRAZOLAM | 0.5MG | TABLET, EXTENDED RELEASE / ORAL | 2007-01-31 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A077996-002 | ALPRAZOLAM | 1MG | TABLET, EXTENDED RELEASE / ORAL | 2007-01-31 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A077996-003 | ALPRAZOLAM | 2MG | TABLET, EXTENDED RELEASE / ORAL | 2007-01-31 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A077996-004 | ALPRAZOLAM | 3MG | TABLET, EXTENDED RELEASE / ORAL | 2007-01-31 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A077996-001 | ALPRAZOLAM | 0.5MG | TABLET, EXTENDED RELEASE / ORAL | 2007-01-31 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A077996-002 | ALPRAZOLAM | 1MG | TABLET, EXTENDED RELEASE / ORAL | 2007-01-31 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A077996-003 | ALPRAZOLAM | 2MG | TABLET, EXTENDED RELEASE / ORAL | 2007-01-31 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A077996-004 | ALPRAZOLAM | 3MG | TABLET, EXTENDED RELEASE / ORAL | 2007-01-31 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A077996-001 | ALPRAZOLAM | 0.5MG | TABLET, EXTENDED RELEASE / ORAL | 2007-01-31 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A077996-002 | ALPRAZOLAM | 1MG | TABLET, EXTENDED RELEASE / ORAL | 2007-01-31 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A077996-003 | ALPRAZOLAM | 2MG | TABLET, EXTENDED RELEASE / ORAL | 2007-01-31 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A077996-004 | ALPRAZOLAM | 3MG | TABLET, EXTENDED RELEASE / ORAL | 2007-01-31 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A077996-001 | ALPRAZOLAM | 0.5MG | TABLET, EXTENDED RELEASE / ORAL | 2007-01-31 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A077996-002 | ALPRAZOLAM | 1MG | TABLET, EXTENDED RELEASE / ORAL | 2007-01-31 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A077996-003 | ALPRAZOLAM | 2MG | TABLET, EXTENDED RELEASE / ORAL | 2007-01-31 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A077996-004 | ALPRAZOLAM | 3MG | TABLET, EXTENDED RELEASE / ORAL | 2007-01-31 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A077996-001 | ALPRAZOLAM | 0.5MG | TABLET, EXTENDED RELEASE / ORAL | 2007-01-31 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A077996-002 | ALPRAZOLAM | 1MG | TABLET, EXTENDED RELEASE / ORAL | 2007-01-31 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A077996-003 | ALPRAZOLAM | 2MG | TABLET, EXTENDED RELEASE / ORAL | 2007-01-31 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A077996-004 | ALPRAZOLAM | 3MG | TABLET, EXTENDED RELEASE / ORAL | 2007-01-31 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A077996-001 | ALPRAZOLAM | 0.5MG | TABLET, EXTENDED RELEASE / ORAL | 2007-01-31 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A077996-002 | ALPRAZOLAM | 1MG | TABLET, EXTENDED RELEASE / ORAL | 2007-01-31 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A077996-003 | ALPRAZOLAM | 2MG | TABLET, EXTENDED RELEASE / ORAL | 2007-01-31 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A077996-004 | ALPRAZOLAM | 3MG | TABLET, EXTENDED RELEASE / ORAL | 2007-01-31 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A077996-001 | ALPRAZOLAM | 0.5MG | TABLET, EXTENDED RELEASE / ORAL | 2007-01-31 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A077996-002 | ALPRAZOLAM | 1MG | TABLET, EXTENDED RELEASE / ORAL | 2007-01-31 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A077996-003 | ALPRAZOLAM | 2MG | TABLET, EXTENDED RELEASE / ORAL | 2007-01-31 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A077996-004 | ALPRAZOLAM | 3MG | TABLET, EXTENDED RELEASE / ORAL | 2007-01-31 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A077996-001 | ALPRAZOLAM | 0.5MG | TABLET, EXTENDED RELEASE / ORAL | 2007-01-31 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A077996-002 | ALPRAZOLAM | 1MG | TABLET, EXTENDED RELEASE / ORAL | 2007-01-31 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A077996-003 | ALPRAZOLAM | 2MG | TABLET, EXTENDED RELEASE / ORAL | 2007-01-31 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A077996-004 | ALPRAZOLAM | 3MG | TABLET, EXTENDED RELEASE / ORAL | 2007-01-31 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A077996-001 | ALPRAZOLAM | 0.5MG | TABLET, EXTENDED RELEASE / ORAL | 2007-01-31 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A077996-002 | ALPRAZOLAM | 1MG | TABLET, EXTENDED RELEASE / ORAL | 2007-01-31 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A077996-003 | ALPRAZOLAM | 2MG | TABLET, EXTENDED RELEASE / ORAL | 2007-01-31 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A077996-004 | ALPRAZOLAM | 3MG | TABLET, EXTENDED RELEASE / ORAL | 2007-01-31 | 5bbf6a4d5a75… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
FDA-Initiated Inactive NDC Indexing#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63629-1541-1 | EA - Each | 63629-1541 | 8b23588f-d794-4184-b666-39f3cc638abb | 1 | 2012-07-24 |
| 63629-1541-2 | EA - Each | 63629-1541 | 4c33b02c-d5f0-4a95-a390-1788bdaa0b2c | 1 | 2012-07-24 |
| 63629-1541-3 | EA - Each | 63629-1541 | dbfa7cc7-403b-4409-a425-0b8529bc2a86 | 1 | 2012-07-24 |
| 63629-1541-4 | EA - Each | 63629-1541 | b840d2d4-6a91-45b2-a6d5-64d678180672 | 1 | 2012-07-24 |
| 63629-1541-5 | EA - Each | 63629-1541 | b7e00dc9-abff-4ee3-850f-95a0c593694e | 1 | 2012-07-24 |
| 63629-1541-6 | EA - Each | 63629-1541 | 33bb5941-369f-4187-ac73-52400f9e2e8d | 1 | 2012-07-24 |
| 63629-1541-7 | EA - Each | 63629-1541 | 321370ae-a80a-4de4-bba7-455329cab992 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| ALPRAZOLAM | ACTIVE INGREDIENT | YU55MQ3IZY | ALPRAZOLAM EXTENDED-RELEASE (ALPRAZOLAM) TABLET, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 3 | |
| ALPRAZOLAM | ACTIVE MOIETY | YU55MQ3IZY | ALPRAZOLAM EXTENDED-RELEASE (ALPRAZOLAM) TABLET, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 3 | |
| HYPROMELLOSES | INACTIVE INGREDIENT | 3NXW29V3WO | ALPRAZOLAM EXTENDED-RELEASE (ALPRAZOLAM) TABLET, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 3 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | ALPRAZOLAM EXTENDED-RELEASE (ALPRAZOLAM) TABLET, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 3 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | ALPRAZOLAM EXTENDED-RELEASE (ALPRAZOLAM) TABLET, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 3 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | ALPRAZOLAM EXTENDED-RELEASE (ALPRAZOLAM) TABLET, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 3 |